Trial
NCT01875848
Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain
Phase IVTERMINATEDSAFETYConfidence: HIGH
Sponsor
VA Office of Research and Development
Collaborators
—
Condition
Pain
Intervention
buprenorphine/naloxone
Why stopped
Data safety monitoring board recommended due to low recruitment yield.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-12-21